14.07.2016 17:35:13
|
Invitation to discuss Actelion's half year results 2016
Actelion Pharmaceuticals Ltd / Invitation to discuss Actelion's half year results 2016 . Processed and transmitted by Nasdaq OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Dear member of the investment community,
Actelion Ltd will announce its financial results for the first six months of 2016 on Thursday, 21 July 2016, at 07:00 hrs CEST.
An investor conference call and webcast will be held at 14:00 hrs CEST to discuss the results.
To support your preparations, consensus estimates can be found under www.actelion.com/consensus-estimate
Date/Time:
21 July 2016 | 14:00 hrs - 15:00 hrs | Basel |
13:00 hrs - 14:00 hrs | London | |
08:00 hrs - 09:00 hrs | New York |
Conference Call Connect #:
Dial-in participants should start calling the number below 10-15 minutes before the conference is due to start.
Dial: | Europe: | +41 (0)44 583 18 01 |
UK: | +44 (0) 203 009 24 60 | |
US: | +1 855 402 77 67 |
Participant's mode:
Listen-Only with possibility to open individual lines during Q&A session. Participants will be asked for their name and company.
Webcast Access:
Webcast participants should go to the Actelion website http://www.actelion.com 10-15 minutes before the conference is due to start.
Participant's mode: Listen-Only
Webcast Replay:
The archived Investor Webcast will be available for replay through http://www.actelion.com/ approximately 60 minutes after the call has ended.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Actelion Pharmaceuticals Ltd via Globenewswire
--- End of Message ---
Actelion Pharmaceuticals Ltd
Gewerbestrasse 16 Allschwil Switzerland
ISIN: CH0010532478;
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Actelion Ltd.mehr Nachrichten
Keine Nachrichten verfügbar. |